ESRX Stock UPDATES Express Scripts (ESRX) 70.17 08/02/2014 1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Express Scripts (ESRX) 70.17 $ESRX

Stock Market Today: Stocks Mixed as Fed Cuts Bond Buying to $25 Billion
at The Street - Wed Jul 30, 3:31PM CDT
Major U.S. stock markets are mixed on Wednesday as the Federal Reserve maintains its federal funds rate and cuts monthly bond buying by $10 billion to $25 billion.

Express Scripts (ESRX) Stock Storming The Castle Today
at The Street - Wed Jul 30, 11:08AM CDT
Trade-Ideas LLC identified Express Scripts (ESRX) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Express Scripts Beats on Earnings & Sales, Adjusts Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 10:00AM CDT
Express Scripts (ESRX) reported higher than expected earnings in the second quarter.

Will This Price Target Decrease Hurt Express Scripts (ESRX) Stock Today?
at The Street - Wed Jul 30, 8:14AM CDT
Jefferies decreased its price target on Express Scripts (ESRX) to $80 from $86 and set a "buy" rating.

Express Scripts 2Q profit falls 5.1 percent
AP - Tue Jul 29, 4:26PM CDT
ST. LOUIS (AP) — Express Scripts Holding Co. (ESRX) on Tuesday reported net income that decreased by 5.1 percent in its second quarter, and beat analysts' expectations.

After Yesterday's Rally of 2.09% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Jul 29, 3:53PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $65.93 to a high of $67.95. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $66.99 on volume of 7.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Express Scripts Rises 2.09% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Jul 29, 3:53PM CDT
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $65.93 to a high of $67.95. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $66.99 on volume of 7.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Why Express Scripts (ESRX) Stock Is Up in After-Hours Trading Today
at The Street - Tue Jul 29, 3:48PM CDT
Express Scripts (ESRX) is gaining after-hours Tuesday after beating analysts' estimates for earnings and revenue in the second quarter.

Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point
PR Newswire - Tue Jul 29, 3:25PM CDT
Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 second quarter net income attributable to Express Scripts stockholders of $515.2 million, or $0.67 per diluted share. Adjusted earnings per diluted share, as detailed in Table 4, was $1.23 for the second quarter.1

American Express, Newmont Mining, Panera Bread, 4 Others Set to Report
at The Street - Tue Jul 29, 8:32AM CDT
The earnings calendar is crowded after the closing bell today as Amgen, Express Scripts, Trinity Industries and U.S. Steel join the headliners.

Program Launches, Earning Results, Upcoming Financial Releases, and Technical Updates - Research Reports on Express Scripts, Cigna, Health Net, WellCare and Molina
PR Newswire - Tue Jul 29, 7:10AM CDT
Today, Analysts Review released its research reports regarding Express Scripts Holding Company (NASDAQ: ESRX), Cigna Corp. (NYSE: CI), Health Net, Inc. (NYSE: HNT), WellCare Health Plans, Inc. (NYSE: WCG) and Molina Healthcare, Inc. (NYSE: MOH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5206-100free.

Will Express Scripts Miss Earnings Estimates this Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 4:10PM CDT
Express Scripts (ESRX) is set to report second quarter results on Jul 29, 2014.

Why Horizon Pharmaceuticals (HZNP) Is Plummeting Today
at The Street - Mon Jul 28, 1:25PM CDT
Horizon Pharmaceuticals (HZNP) plummeted Monday after the company said CVS (CVS) and Express Scripts (ESRX) would put Horizon's two best-selling drugs on their exclusion lists at the beginning of 2015.

Express Scripts expansion could mean 1,500 jobs
AP - Mon Jul 28, 12:29PM CDT
ST. LOUIS (AP) — The nation's largest company that manages pharmacy benefits is opening a new office building in St. Louis County as part of an expansion, which is expected to add 1,500 jobs over the next five years.

Video: Horizon Pharma Drugs Dumped By Pharmacies
at Investor's Business Daily - Mon Jul 28, 10:14AM CDT
Shares of specialty drugmaker Horizon Pharma (HZNP) were down 30% on the stock market today after two major pharmacy benefit managers removed its drugs from their formularies. Horizon disclosed in an SEC filing that Express Scripts (ESRX) and...

Access to Horizon Pharma Drugs Cut By Two Leading PBMs
at The Street - Mon Jul 28, 9:56AM CDT
Express Scripts and CVS Caremark are the largest and second-largest pharmacy benefits managers in the U.S. Both have been aggressive with efforts to rein in ever-escalating drug prices.

Express Scripts (ESRX) Is Today's Unusual Social Activity Stock
at The Street - Mon Jul 28, 9:15AM CDT
Trade-Ideas LLC identified Express Scripts (ESRX) as an unusual social activity candidate

Will This Price Target Cut Hurt Express Scripts (ESRX) Stock Today?
at The Street - Mon Jul 28, 8:24AM CDT
UBS lowers its price target for Express Scripts (ESRX) to $82 from $90 with a 'buy' rating.

Downtrend Call Working As Express Scripts Stock Falls 12.3% (ESRX)
Comtex SmarTrend(R) - Thu Jul 24, 10:05AM CDT
SmarTrend identified a Downtrend for Express Scripts (NASDAQ:ESRX) on March 27th, 2014 at $75.39. In approximately 4 months, Express Scripts has returned 12.32% as of today's recent price of $66.10.

Downgrade Alert for Express Scripts (ESRX)
Comtex SmarTrend(R) - Thu Jul 24, 6:57AM CDT
Express Scripts (NASDAQ:ESRX) was downgraded from Buy to Neutral at Cleveland Research today. The stock closed yesterday at $66.02 on volume of 6.6 million shares, above average daily volume of 4.7 million. Potential upside of 20.7% exists for Express Scripts, based on a current level of $66.02 and analysts' average consensus price target of $79.68. The stock should find initial resistance at its 50-day moving average (MA) of $69.14 and further resistance at its 200-day MA of $70.06.



Scroll down for more posts ▼

Top 10 Most Recent News Articles

First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 10

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

NCLA Seeks Supreme Court's Support for Presidential Authority

Updated Category News Views 160

NCLA Seeks Supreme Court's Support for Presidential Authority Washington, DC, the New Civil Liberties Alliance (NCLA) has taken significant legal action recently, filing an amicus curiae brief in a pivotal Supreme Court case concerning presidential power. The organization argues for the President's authority to remove a member of the Federal Reserve Board, specifically...

Continue Reading
ONAR CEO Claude Zdanow to Discuss AI Innovations at 2025 Event

Updated Category News Views 226

ONAR CEO Claude Zdanow to Present at GenAi Week SV 2025 ONAR Holding Corporation (OTCQB: ONAR), a prominent marketing-technology firm, has announced an exciting opportunity for its CEO, Claude Zdanow, to present at GenAi Week SV 2025. This key industry event promises to gather innovators and leaders in the field of generative AI, uniting enthusiasts eager to explore...

Continue Reading
Foremost Clean Energy Clarifies Spin-Out and Trading Halt

Updated Category News Views 148

Understanding the Recent Updates from Foremost Clean Energy Foremost Clean Energy Ltd. (NASDAQ: FMST), a burgeoning player in North America's uranium and lithium exploration sector, aims to clarify important developments regarding its operations, particularly the anticipated spin-out of its gold and silver properties into a new entity, Rio Grande Resources Ltd. Clarity on...

Continue Reading
Nexar and NVIDIA Pioneer Autonomous Vehicle Solutions Together

Updated Category News Views 310

Nexar and NVIDIA Join Forces for Automotive Innovation The collaboration between Nexar and NVIDIA is set to revolutionize the field of autonomous vehicles. By leveraging Nexar's vast real-world vision data alongside NVIDIA's powerful computing capabilities, this partnership aims to redefine safety and innovation in mobility solutions. Transforming Data into Actionable...

Continue Reading
National Grid Renewables Launches 117 MW Solar Project

Updated Category News Views 175

National Grid Renewables Breaks Ground on Sycamore Creek Solar Project The Sycamore Creek Solar Project is an exciting new initiative that demonstrates National Grid Renewables' commitment to sustainable energy. Located within the PJM market, this project has a capacity of 117 megawatts (MW) and is set to make significant contributions to the local economy. Commitment to...

Continue Reading